Both Toxoplasma gondii and Plasmodium are Apicomplexan protozoa that share common metabolic pathways and potential drug targets. The objective of this study was to examine the antiToxoplasma activity of nine West African plants with known activity against P. falciparum. The extracts were obtained from parts of plant commonly used, by most traditional healers, in the form of infusion or as water decoction. The in vitro activity of plant extracts on T. gondii was assessed on MRC5 tissue cultures and was quantified by enzyme-linked immunoassay. Aqueous extracts from Vernonia colorata were found to be inhibitory for Toxoplasma growth at concentrations > 10 mg/L, with an IC50 of 16.3 mg/L. A ten-fold gain in activity was obtained when organic solvents such as dichloromethane, acetone or ethanol were used to extract V. colorata's active principles. These extracts were inhibitory at concentrations as low as 1 mg/L, with IC50 of 1.7, 2.6 and 2.9 mg/L for dichloromethane, acetone and ethanol extracts respectively. These results indicate a promising source of new anti-Toxop/asma drugs from V. colorata and African medicinal plants.
Résumé : ACTIVITÉ ANTI-TOXOPLASMOSE D'EXTRAITS VÉGÉTAUX UTILISÉS DANS LA MÉDECINE TRADITIONNELLE D'AFRIQUE DE L'OUEST

mg/L), l'acétone (Cl50 = 2,6 mg/L) et l'éthanol (CI50 = 2,9 mg/L). Ces résultats indiquent une source prometteuse de nouveaux médicaments anti-Toxoplasma à partir de V. colorata et des plantes médicinales africaines.
INTRODUCTION
T raditional medicine could be a promising source of new parasitic drugs. Significant successes were achieved on antimalarial products with new derivatives extracted from plants like Qinghaosu (Li & Rieckmann, 1992) . In Africa, the use of indige nous plants plays an important role in the treatment of a variety of parasitic diseases as reviewed by Phillipson (1986) . Plants are used by traditional healers to treat and cure malaria symptoms and we previously confirmed the in vitro anti-malarial activity of several aqueous plant extracts against chloroquine-sensitive and chloroquine-resistant strains of P. falciparum (Benoit et al., 1995 (Benoit et al., , 1996 . which probably act on protein biosynthesis in the apicoplast, i.e. a structure which is present in Plasmodium and in T. gondii (Derouin, 1999; Soldati, 1999) . Thus, the objective of this study was to determine if nine west
African plants with known anti-P. falciparum activity could also be inhibitory for T. gondii growth in vitro. Extracts were prepared from different parts of the plants (see Table I ) that had been air-dried for 10-days at 33° C, then pulverized into powder (sift: 250).
MATERIAL AND METHODS
PLANT EXTRACTS
Aqueous extracts (decoction and infusion) were pre pared from 50 g of dried powder as previously des cribed (Benoit, 1995) . For infusion, dried powder was added into 500 ml of distilled boiling water that was then removed from heat and allowed to stand for 10 min. For the decoction, powder was added to boi ling water, kept at 100° C for 10 min and then allowed to sediment for 10 min. The suspensions were centri- Derouin, 1999; Remington et al, 1995; Slater, 1993; Pradines et al, 1998) . In this regards, indigenous plants could be a promising source of new anti-parasitic drugs, as already evidenced for several antimalarials such as Qinghaosu (artemisinin). Interestingly, the anti-parasitic effect of this drug and its derivatives is not restricted to Plasmodium since it was also found to be inhibitory for Toxoplasma gondii in vitro (Holfels et al., 1994) .
In a previous study, we examined the in vitro anti-plas- Gessler et al., 1994; Sohni et al., 1995; Valsaraj et al., 1997) . Similarly, L. multiflora presents antibacterial and antiplasmodial activities (Valentin et al, 1995) . 
